Message from the Director & Board
For BPRC and its staff, the year 2022 was, seen from a scientific point of view, very productive. We continued our research on various COVID-19 vaccine candidates but had more time to focus on other biomedical relevant topics as well. All the different departments have summarized their major achievement on another section of this Annual Report and a comprehensive overview is listed on the news item section on our webpage.
Altogether we published 50 manuscripts in the peer reviewed scientific literature with an average impact factor of 9.3.
This high number is due to the fact that we published a substantial segment of our research output in leading scientific journals. We consider this as a major achievement and are very proud that improved our publication standards. On top of that, one of our postdocs, Jesse Bruijnesteijn, received the Julia Bodmer young investigator award at the EFI meeting which was held in Amsterdam.
This year was due to all the hard work financially sound and we closed the books with a small negative result of 8000 euro.
Prof. dr. R.E. Bontrop
Director of BPRC